Advanced Dry Eye Treatment

A Novel Nonsurgical Non-Drug Alternative

Envision is the new in-office standard revolutionizing procedures in small and delicate areas. This ground breaking, nonsurgical device, allows for safe and highly efficacious dermatological procedures in the skin and subdermal layers of the face and periorbital region. It deploys multiple programmable modalities that work synergistically to deliver precision treatments.

• Forma-I: bipolar radiofrequency (RF)

• Lumecca: intense pulsed light (IPL)

• Forma: bipolar radiofrequency (RF)
  
  

Envision's small-size applicators provide precise thermal and depth control, allowing for safe and highly efficacious procedures in the more delicate subdermal layers of smaller regions. The patented technologies offer providers reproducible and predictable treatment options for optimal patient outcomes. With Envision, you can provide personalized care with multiple advanced treatments.

Forma-I Precision Tissue Treatments

Forma-I is FDA cleared for the relief of minor muscle aches and pain, relief of muscle spasms, and temporary improvement of local blood circulation. Forma-I is an innovative thermal technology designed to deliver targeted bipolar radiofrequency energy to small delicate zones. The compact size reaches optimal treatment temperatures up to 43°C, providing comfortable, precise, and uniform volumetric deep heating. Designed with unprecedented safety, the small size applicator, precision RF depth control, and intelligent epidermal monitoring with continuous feedback, ensure Forma-I is a safe non-drug alternative.

Lumecca: Intense Pulsed Light (IPL)

Lumecca, with the detachable Lumecca-I spot size adaptor, delivers precise, targeted Intense Pulsed Light (IPL) procedures. Lumecca is FDA cleared for the treatment of benign pigmented epidermal lesions, including dyschromia, hyperpigmentation, melasma, ephelides (freckles); The treatment of benign cutaneous vascular lesions, including port wine stains, facial, truncal and leg telangiectasias, rosacea, erythema of rosacea, angiomas and spider angiomas, poikilodenna of Civatte, superficial leg veins, and venlous malformations.Optimized for skin tones I-IV, Lumecca was developed with an advanced Xenon flash lamp producing 40% of total pulse energy in the 500-600 nm range.